Drug Trial Radar · NCT06881784
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
590
Planned (sponsor's estimate)
Start
May 6, 2025
Primary completion
Dec 1, 2027
Study completion Dec 1, 2030
Sponsor
- Lead sponsor
- Revolution Medicines, Inc.Industry
- Sponsor type
- Industry
- First posted
- Mar 18, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to docetaxel.
Conditions
- NSCLC (Non-small Cell Lung Cancer)
- Non-Small Cell Lung Cancer
- NSCLC
- NSCLC (Non-small Cell Lung Carcinoma)
- NSCLC (Advanced Non-small Cell Lung Cancer)
Interventions
daraxonrasibDrug
oral tablets
docetaxelDrug
intravenous (IV) infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression free survival (PFS) per Blinded Independent Central Review (BICR) in the RAS G12X-C population (i.e RAS G12X excluding G12C)Time frame: Up to approximately 4 years
- Overall survival (OS) in the RAS G12X-C populationTime frame: Up to approximately 4 years
Locations
199 sites in 19 countries. Site status is shown where the registry gives one.
Alabama Oncology
Birmingham, Alabama · Active not recruiting
Loma Linda University
Loma Linda, California · Active not recruiting
MemorialCare Long Beach Medical Center
Long Beach, California · Active not recruiting
UC Irvine Health
Orange, California · Recruiting
UCHealth Memorial Hospital Central
Colorado Springs, Colorado · Active not recruiting
Yale University, Smillow Cancer Center
New Haven, Connecticut · Active not recruiting
Florida Cancer Specialists & Research Institute - South
Fort Myers, Florida · Active not recruiting
BRCR Global
Plantation, Florida · Active not recruiting
Florida Cancer Specialists & Research Institute - North
St. Petersburg, Florida · Active not recruiting
Cleveland Clinic Martin North
Stuart, Florida · Active not recruiting
Florida Cancer Specialists & Research Institute - East
West Palm Beach, Florida · Active not recruiting
University Cancer and Blood Center
Athens, Georgia · Active not recruiting
Piedmont Healthcare, Inc
Atlanta, Georgia · Active not recruiting
Winship Cancer Institute
Atlanta, Georgia · Active not recruiting
Rush University Medical Center
Chicago, Illinois · Active not recruiting
University of Illinois Cancer Center
Chicago, Illinois · Active not recruiting
University of Chicago Medical Center
Chicago, Illinois · Active not recruiting
Community Health Network
Indianapolis, Indiana · Active not recruiting
University of Iowa Health Care Cancer Services Quad Cities
Bettendorf, Iowa · Active not recruiting
University of Iowa Hospitals & Clinics
Iowa City, Iowa · Active not recruiting
University of Iowa Health Care, Mission Cancer + Blood
Waukee, Iowa · Active not recruiting
The University of Kansas Cancer Center
Westwood, Kansas · Active not recruiting
University of Maryland Greenebaum Comprehensive Cancer Center.
Baltimore, Maryland · Active not recruiting
Johns Hopkins University of Medicine
Baltimore, Maryland · Active not recruiting
Trinity Health Ann Arbor Hospital
Ann Arbor, Michigan · Active not recruiting
Karmanos Cancer Institute
Detroit, Michigan · Active not recruiting
Brigitte Harris Cancer Pavilion BHCP
Detroit, Michigan · Active not recruiting
Washington University School of Medicine - Siteman Cancer Center
St Louis, Missouri · Active not recruiting
St. Vincent Frontier Cancer Center
Billings, Montana · Active not recruiting
Comprehensive Cancer Centers of Nevada
Henderson, Nevada · Active not recruiting
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire · Active not recruiting
John Theurer Cancer Center at Hackensack UMC
Hackensack, New Jersey · Active not recruiting
Morristown Medical Center (MMCORC)
Morristown, New Jersey · Active not recruiting
Roswell Park Cancer Institute
Buffalo, New York · Active not recruiting
Memorial Sloan Kettering Cancer Center
New York, New York · Active not recruiting
Montefiore Medical Center
The Bronx, New York · Active not recruiting
UNC Lineberger Comprehensive Cancer Center at University of North Carolina
Chapel Hill, North Carolina · Active not recruiting
TriHealth Cancer & Blood Institute Research
Cincinnati, Ohio · Active not recruiting
Taylor Cancer Research Center
Maumee, Ohio · Active not recruiting
Oncology Associates of Oregon PC
Eugene, Oregon · Active not recruiting
Showing 40 of 199 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.